Literature DB >> 2065481

Enhanced vasoconstriction by serotonin in rabbit carotid arteries with atheroma-like lesions in vivo.

C G Sobey1, G J Dusting, O L Woodman.   

Abstract

1. In a new animal model which mimics the cellular events of early human atherosclerosis, atheroma-like lesions were produced by positioning a hollow silastic collar around the common carotid arteries of rabbits. The functional significance of these arterial lesions on blood flow responses to vasoactive agents was then studied in anaesthetized rabbits in vivo. 2. After 1 week of lesion development, resting blood flow was lower in atherosclerotic (cuffed) carotid arteries compared with the contralateral, sham-operated control arteries. 3. Intra-carotid injection of serotonin (0.01-1 microgram) produced dose-dependent increases in blood flow in control arteries, but produced either smaller increases or decreases in flow in cuffed arteries. Serotonin caused complete vasospasm (zero blood flow) in one of six rabbits. 4. Acetylcholine (0.0001-0.01 microgram, intra-carotid) produced smaller increases in blood flow in cuffed arteries compared with controls. 5. These data support the proposal that morphological and functional alterations in large arteries in the early stages of atherogenesis play an important role in determining blood flow in vivo. The increased vascular reactivity to serotonin which accompanies development of the lesions might contribute to vasospasm.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065481     DOI: 10.1111/j.1440-1681.1991.tb01465.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  3 in total

1.  Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery.

Authors:  I S Geerts; K E Matthys; A G Herman; H Bult
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure.

Authors:  Günay Yetik Anacak; Levent Ustünes; Ozlem Yilmaz Dilsiz; Adviye Ergul
Journal:  Vascul Pharmacol       Date:  2010-08-12       Impact factor: 5.773

3.  Analysis of the agonist activity of fenoldopam (SKF 82526) at the vascular 5-HT2 receptor.

Authors:  M I Christie; D Harper; G W Smith
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.